MRK - CIK 0000310158
The table below shows Merck & Co., Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.33B | $18.17B | $8.01B | $8.63B | $14.59B | $11.30B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $12.21B | $12.12B | $11.85B | $10.79B | $11.38B | $11.64B |
| Inventory | $6.48B | $6.44B | $6.60B | $6.20B | $6.24B | $6.47B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $35.02B |
| $47.56B |
| $37.06B |
| $35.50B |
| $40.36B |
| $38.20B |
| Property, plant & equipment | $25.43B | $25.64B | $25.24B | $24.79B | $23.45B | $23.22B |
| Goodwill | $21.58B | $21.59B | $21.59B | $21.68B | $21.70B | $21.16B |
| Total assets | $128.69B | $129.55B | $117.52B | $115.12B | $117.53B | $112.63B |
| Accounts payable | $3.86B | $4.15B | $3.89B | $3.78B | $3.59B | $3.52B |
| Total current liabilities | $26.95B | $28.63B | $26.04B | $25.17B | $29.59B | $26.06B |
| Long-term debt | $46.67B | $39.97B | $33.97B | $33.48B | $34.98B | $34.72B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $66.72B | $72.23B | $68.48B | $66.10B | $61.38B | $60.19B |
| Total equity | $45.88B | $51.85B | $48.99B | $48.34B | $44.50B | $43.58B |